Abstract Details

Title Efficacy and Safety of Ralfinamide in a 8-Week, Randomised, Double-Blind, Placebo Controlled, International Trial in Patients with Neuropathic Pain (NP). Ralfinamide 001 Study Group

Topic Peripheral Nerve

Presentation(s) (-)

Poster/Presentation
Number 179

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Ravi Anand (Novartis Pharmacueticals)	No disclosure on file
	No disclosure on file
Stefano M. Rossetti, MD (Rossetti Consulting Sas)	No disclosure on file
	No disclosure on file
Paolo Marchettini, MD	No disclosure on file
Burkhard Gustorff, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��